Editorial
doi: 10.1053/j.gastro.2014.04.026.
Epub 2014 Apr 26.
Staging for hepatocellular carcinoma: complex and confusing
Affiliations
- PMID: 24780213
- DOI: 10.1053/j.gastro.2014.04.026
Item in Clipboard
Editorial
Staging for hepatocellular carcinoma: complex and confusing
Gastroenterology.
2014 Jun.
No abstract available
Comment on
-
Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma.Gastroenterology. 2014 Jun;146(7):1691-700.e3. doi: 10.1053/j.gastro.2014.02.032. Epub 2014 Feb 25. Gastroenterology. 2014. PMID: 24583061
Similar articles
-
Usefulness of the HKLC vs. the BCLC staging system in a European HCC cohort.J Hepatol. 2015 Feb;62(2):492-3. doi: 10.1016/j.jhep.2014.08.035. Epub 2014 Sep 4. J Hepatol. 2015. PMID: 25194894 No abstract available.
-
Classification and staging of hepatocellular carcinoma: an aid to clinical decision-making.Clin Liver Dis. 2015 May;19(2):277-94. doi: 10.1016/j.cld.2015.01.011. Clin Liver Dis. 2015. PMID: 25921663 Review.
-
Predicting survival in early hepatocellular carcinoma.Gut. 2005 Mar;54(3):328-9. doi: 10.1136/gut.2004.052092. Gut. 2005. PMID: 15710977 Free PMC article. Review. No abstract available.
-
Staging systems for hepatocellular carcinoma: should we all use the BCLC system?J Hepatol. 2006 Apr;44(4):630-2. doi: 10.1016/j.jhep.2006.02.003. Epub 2006 Feb 17. J Hepatol. 2006. PMID: 16503077 No abstract available.
-
The Prognostic Ability of Major Hepatocellular Carcinoma Staging Systems Is Improved by Including a Treatment Variable.Dig Dis Sci. 2018 Sep;63(9):2277-2284. doi: 10.1007/s10620-018-5132-2. Epub 2018 May 28. Dig Dis Sci. 2018. PMID: 29808245
Cited by
-
Prognostic Hypoxia-Angiogenesis-Related Gene Signature in Hepatocellular Carcinoma, in Which HILPDA Contributes to Tumor Progression.J Inflamm Res. 2024 Aug 27;17:5663-5683. doi: 10.2147/JIR.S476388. eCollection 2024. J Inflamm Res. 2024. PMID: 39219818 Free PMC article.
-
Immunohistochemical Coexpression of Epithelial Cell Adhesion Molecule and Alpha-Fetoprotein in Hepatocellular Carcinoma.Can J Gastroenterol Hepatol. 2018 Jul 19;2018:5970852. doi: 10.1155/2018/5970852. eCollection 2018. Can J Gastroenterol Hepatol. 2018. PMID: 30112355 Free PMC article.
-
Nomograms to predict the long-time prognosis in patients with alpha-fetoprotein negative hepatocellular carcinoma following radical resection.Cancer Med. 2020 Apr;9(8):2791-2802. doi: 10.1002/cam4.2944. Epub 2020 Feb 25. Cancer Med. 2020. PMID: 32096346 Free PMC article. Clinical Trial.
-
Comparison of AI chatbot predicted and realworld survival outcomes in hepatocellular carcinoma.Sci Rep. 2025 Jul 1;15(1):21728. doi: 10.1038/s41598-025-06591-9. Sci Rep. 2025. PMID: 40596129 Free PMC article.
-
Reply: Heterogeneity of intermediate-stage HCC necessitates personalized management including surgery.Nat Rev Clin Oncol. 2015 Jan;12(1):10. doi: 10.1038/nrclinonc.2014.122-c2. Epub 2014 Nov 25. Nat Rev Clin Oncol. 2015. PMID: 25421282 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
